FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W179173868> ?p ?o ?g. }

• W179173868 abstract "Home > April 1, 2010 - Volume 10 - Issue 2 > Predictors of Annual Pharmaceutical Costs in Australia for C... American Journal of Cardiovascular Drugs: 1 April 2010 - Volume 10 - Issue 2 - pp 85-94 doi: 10.2165/11530670-000000000-00000 Original Research Articles Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease: Analysis of Australian Data from the REACH Registry Ademi, Zanfina1; Liew, Danny2; Hollingsworth, Bruce3; Steg, Ph. Gabriel4; Bhatt, Deepak L.5; Reid, Christopher M.1; on behalf of the REACH Registry Investigators Abstract Background: Cardiovascular disease (CVD) remains a leading cause of death across the world and poses a significant economic burden. Research regarding per-person use and cost of cardiovascular pharmaceuticals in Australia, as well as potential predictors of pharmaceutical costs in populations using the ‘bottom up’ costing approach, is limited. Previous studies have adopted ‘top down’ costing approaches and have been based largely on hypothetical examples and considered only inpatient settings. Objective: To determine the distribution of pharmaceutical costs (from a governmental perspective) related to each cardiovascular risk factor for individuals with, or at high risk of, CVD by analysing data for Australian participants enrolled in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Methods: 2873 participants were recruited for the REACH Registry through 273 general (primary care) practices in Australia. Included among data collected at baseline was a cardiovascular medicines review. Average weighted costs per person were estimated using Government-reimbursed prices (2007). Annual costs were stratified by sex, age, disease group and other co-morbidities. A multivariate linear regression model was utilized to reveal the predictors of the pharmaceutical costs. Results: The average annual median cost of cardiovascular pharmaceuticals per person was Australian dollars ($A)1310. Use of lipid-lowering agents, non-aspirin (acetylsalicylic acid) antiplatelet agents and thiazolidinediones (glitazones) added significantly to the average annual per-person costs. The multivariate regression model showed that the predictors of annual pharmaceutical costs were dyslipidemia (β coefficient value [marginal annual cost associated with a condition] $A691; p < 0.001), hypertension ($A346; p < 0.001), vascular disease ($A340; p < 0.001), diabetes mellitus ($A298; p < 0.001), and obesity ($A52; p = 0.03). The same predictors, together with sex, were shown to have an impact on the number of medicines used. Conclusions: Among community-based Australians with, or at risk of, CVD, independent drivers of annual cardiovascular pharmaceutical costs are dyslipidemia (which accounts for half of per-person costs), followed by hypertension, established CVD, and diabetes. Obesity also independently adds to the cost of cardiovascular pharmaceuticals in community-based Australians with, or at risk of, CVD." @default.
• W179173868 created "2016-06-24" @default.
• W179173868 creator A5012209049 @default.
• W179173868 creator A5017617474 @default.
• W179173868 creator A5026004870 @default.
• W179173868 creator A5042141112 @default.
• W179173868 creator A5071656006 @default.
• W179173868 creator A5086722660 @default.
• W179173868 date "2010-04-01" @default.
• W179173868 modified "2023-09-27" @default.
• W179173868 title "Predictors of annual pharmaceutical costs in Australia for participants with or at risk of cardiovascular disease : analysis of Australian data from the REACH Registry" @default.
• W179173868 hasPublicationYear "2010" @default.
• W179173868 type Work @default.
• W179173868 sameAs 179173868 @default.
• W179173868 citedByCount "0" @default.
• W179173868 crossrefType "journal-article" @default.
• W179173868 hasAuthorship W179173868A5012209049 @default.
• W179173868 hasAuthorship W179173868A5017617474 @default.
• W179173868 hasAuthorship W179173868A5026004870 @default.
• W179173868 hasAuthorship W179173868A5042141112 @default.
• W179173868 hasAuthorship W179173868A5071656006 @default.
• W179173868 hasAuthorship W179173868A5086722660 @default.
• W179173868 hasConcept C121955636 @default.
• W179173868 hasConcept C126322002 @default.
• W179173868 hasConcept C138816342 @default.
• W179173868 hasConcept C138885662 @default.
• W179173868 hasConcept C144024400 @default.
• W179173868 hasConcept C144133560 @default.
• W179173868 hasConcept C149923435 @default.
• W179173868 hasConcept C159110408 @default.
• W179173868 hasConcept C160735492 @default.
• W179173868 hasConcept C164624739 @default.
• W179173868 hasConcept C17744445 @default.
• W179173868 hasConcept C199539241 @default.
• W179173868 hasConcept C2778137410 @default.
• W179173868 hasConcept C2779134260 @default.
• W179173868 hasConcept C41895202 @default.
• W179173868 hasConcept C512399662 @default.
• W179173868 hasConcept C524218345 @default.
• W179173868 hasConcept C71924100 @default.
• W179173868 hasConcept C99454951 @default.
• W179173868 hasConceptScore W179173868C121955636 @default.
• W179173868 hasConceptScore W179173868C126322002 @default.
• W179173868 hasConceptScore W179173868C138816342 @default.
• W179173868 hasConceptScore W179173868C138885662 @default.
• W179173868 hasConceptScore W179173868C144024400 @default.
• W179173868 hasConceptScore W179173868C144133560 @default.
• W179173868 hasConceptScore W179173868C149923435 @default.
• W179173868 hasConceptScore W179173868C159110408 @default.
• W179173868 hasConceptScore W179173868C160735492 @default.
• W179173868 hasConceptScore W179173868C164624739 @default.
• W179173868 hasConceptScore W179173868C17744445 @default.
• W179173868 hasConceptScore W179173868C199539241 @default.
• W179173868 hasConceptScore W179173868C2778137410 @default.
• W179173868 hasConceptScore W179173868C2779134260 @default.
• W179173868 hasConceptScore W179173868C41895202 @default.
• W179173868 hasConceptScore W179173868C512399662 @default.
• W179173868 hasConceptScore W179173868C524218345 @default.
• W179173868 hasConceptScore W179173868C71924100 @default.
• W179173868 hasConceptScore W179173868C99454951 @default.
• W179173868 hasLocation W1791738681 @default.
• W179173868 hasOpenAccess W179173868 @default.
• W179173868 hasPrimaryLocation W1791738681 @default.
• W179173868 hasRelatedWork W1919647392 @default.
• W179173868 hasRelatedWork W1981322012 @default.
• W179173868 hasRelatedWork W2008020777 @default.
• W179173868 hasRelatedWork W2015835669 @default.
• W179173868 hasRelatedWork W2020566754 @default.
• W179173868 hasRelatedWork W2050528120 @default.
• W179173868 hasRelatedWork W2085047564 @default.
• W179173868 hasRelatedWork W2090068416 @default.
• W179173868 hasRelatedWork W2159205453 @default.
• W179173868 hasRelatedWork W2181285706 @default.
• W179173868 hasRelatedWork W2336547219 @default.
• W179173868 hasRelatedWork W2474120624 @default.
• W179173868 hasRelatedWork W2765545378 @default.
• W179173868 hasRelatedWork W2770827476 @default.
• W179173868 hasRelatedWork W2911963364 @default.
• W179173868 hasRelatedWork W2954527457 @default.
• W179173868 hasRelatedWork W2968863033 @default.
• W179173868 hasRelatedWork W3049694698 @default.
• W179173868 hasRelatedWork W3130556758 @default.
• W179173868 hasRelatedWork W3135872347 @default.
• W179173868 isParatext "false" @default.
• W179173868 isRetracted "false" @default.
• W179173868 magId "179173868" @default.
• W179173868 workType "article" @default.